The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 30, 2019
Filed:
Oct. 08, 2014
Applicant:
Vascular Therapies, Inc., Cresskill, NJ (US);
Inventors:
Sriram S. Iyer, New York, NY (US);
Nicholas N. Kipshidze, New York, NY (US);
Victor V. Nikolaychik, Mequon, WI (US);
Assignee:
Vascular Therapies, Inc., Cresskill, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61F 2/00 (2006.01); A61K 31/44 (2006.01); A61K 31/436 (2006.01); A61K 9/00 (2006.01); A61K 31/122 (2006.01); A61K 31/337 (2006.01); A61K 31/395 (2006.01); A61K 31/573 (2006.01); A61K 31/727 (2006.01); A61L 31/16 (2006.01); A61M 1/36 (2006.01); A61M 39/02 (2006.01); A61L 27/20 (2006.01); A61L 27/22 (2006.01); A61L 27/44 (2006.01); A61L 27/54 (2006.01); A61M 1/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/436 (2013.01); A61K 9/0024 (2013.01); A61K 31/122 (2013.01); A61K 31/337 (2013.01); A61K 31/395 (2013.01); A61K 31/573 (2013.01); A61K 31/727 (2013.01); A61L 27/20 (2013.01); A61L 27/225 (2013.01); A61L 27/44 (2013.01); A61L 27/54 (2013.01); A61L 31/16 (2013.01); A61M 1/3655 (2013.01); A61M 39/0247 (2013.01); A61L 2300/204 (2013.01); A61L 2300/252 (2013.01); A61L 2300/416 (2013.01); A61M 1/16 (2013.01); A61M 2039/0258 (2013.01); A61M 2039/0261 (2013.01); A61M 2202/0468 (2013.01); A61M 2202/0478 (2013.01);
Abstract
This invention is a prosthetic device generally placed on the outside surface of the vessel or graft which then elutes antiproliferative drugs or agents from a drug-eluting matrix material. Methods of perivascular antiproliferative drug administration also are disclosed.